39 results
6-K
EX-99.3
CANF
Can-Fite Biopharma Ltd
31 Aug 23
Report of Foreign Private Issuer
7:12am
Annual Meeting Proceedings.
Preparatory Work for Pivotal Phase III Psoriasis Study; Can Fite Received Green Light from FDA and EMA— Following positive
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
1 Jun 23
Can-Fite Reports First Quarter 2023 Financial Results & Provides Clinical Update
7:07am
by 2030.
PICLIDENOSON
Green Light from EMA for a Pivotal Phase 3 Psoriasis Study—The European Medicines Agency (EMA) gave Can-Fite a positive opinion
6-K
CANF
Can-Fite Biopharma Ltd
10 Apr 23
Report of Foreign Private Issuer
7:06am
or furnished.
On April 10, 2023, Can-Fite BioPharma Ltd. issued a press release entitled “Can-Fite: EMA Gives Green Light for Piclidenoson Pivotal Phase III
6-K
EX-99.1
CANF
Can-Fite Biopharma Ltd
10 Apr 23
Report of Foreign Private Issuer
7:06am
Exhibit 99.1
Can-Fite: EMA Gives Green Light for Piclidenoson Pivotal Phase III Clinical Trial for Psoriasis Treatment
The Pivotal Study is Aimed
6-K
EX-99.1
hsj58ifm
23 Aug 22
Can-Fite’s Drug Namodenoson Approved for Compassionate Use Treatment of Advanced Liver
7:13am
6-K
EX-99.1
l99p7nkva15a77m
25 Jul 22
Report of Foreign Private Issuer
4:30pm
6-K
EX-99.1
whdmwq 0mx6fbt
2 May 22
Can-Fite’s CEO to Present Namodenoson’s Efficacy in Liver Cancer as Expert Speaker at the Adenosine Pathway Targeted Cancer Immunotherapy Summit
7:09am
6-K
EX-99.1
x3dt2r9he
22 Feb 21
Report of Foreign Private Issuer
7:23am
6-K
EX-99.1
kt5l30sm7okwyryv
13 Feb 20
Notice of Special General Meeting of Shareholders
4:30pm
424B4
vdgoyflht723guwjmx
12 Feb 20
Prospectus supplement with pricing info
6:46am
F-1/A
55zqmncq
3 Feb 20
Registration statement (foreign) (amended)
5:31pm
F-1
sog1dpjk 3o7zto49
24 Jan 20
Registration statement (foreign)
4:40pm
6-K
EX-99.1
9xzc1 5tp4c54uprad
9 Jan 20
Notice of Special General Meeting of Shareholders
4:41pm
6-K
EX-99.1
qi3ar4jbg fj2o9cj
6 Nov 19
2019 Annual General Meeting of Shareholders
4:42pm
20-F/A
4e4jgm7y
2 Apr 19
Annual report (foreign) (amended)
6:52am